查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386936

研究抗体市场报告：2030 年趋势、预测与竞争分析

Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

研究抗体趋势和预测

到 2030 年，全球研究抗体市场预计将达到 55 亿美元，2024 年至 2030 年复合年增长率为 6.5%。这个市场的主要驱动力是由于多发性硬化症和帕金森氏症的增加而对个人化医疗的需求不断增加，以及新药和蛋白质疗法的开发。全球研究抗体市场的未来看起来充满希望，免疫组织化学、萤光、西方印渍术、流式细胞仪、免疫沉淀和 ELISA 市场充满机会。

研究抗体市场洞察

Lucintel预测单株抗体将用于发现和开发针对多种癌症类型的新治疗方法，并且需要高选择性抗体的癌症研究配合措施将会增加。此后，单株抗体在预测期内将继续成为更大的细分市场。

在这个市场中，免疫组织化学可能仍然是最大的部分，因为它在基于细胞的研究中检测酶、抗原、肿瘤抑制基因和癌细胞增殖方面有广泛的应用。

由于对干细胞、医学和癌症研究的兴趣日益浓厚，以及对基于结构的药物设计开发的投资增加，北美在预测期内可能仍是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球研究抗体市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球研究抗体市场趋势（2018-2023）与预测（2024-2030）
  • 全球研究抗体市场（按产品）
    • 一抗
    • 二抗
  • 按类型分類的全球研究抗体市场
    • 单株抗体
    • 多克隆抗体
  • 按技术分類的全球研究抗体市场
    • 免疫组织化学
    • 萤光
    • 西方印渍术
    • 流式细胞仪
    • 免疫沉淀
    • ELISA
    • 其他的
  • 全球研究抗体市场（依最终用途）
    • 学术研究所
    • 合约研究组织
    • 製药和生物技术公司

第四章 2018-2030年区域市场趋势及预测分析

  • 全球研究抗体市场（按地区）
  • 北美研究抗体市场
  • 欧洲研究抗体市场
  • 亚太研究抗体市场
  • 其他区域研究抗体市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球研究抗体市场成长机会（按产品）
    • 按类型分類的全球研究抗体市场成长机会
    • 全球研究抗体市场成长机会（按技术）
    • 全球研究抗体市场成长机会（依最终用途）
    • 按地区分類的全球研究抗体市场成长机会
  • 全球研究抗体市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球研究抗体市场的产能
    • 全球研究抗体市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Abcam
  • Merck
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Santa Cruz Biotechnology
  • PerkinElmer
  • Becton and Dickinson
简介目录

Research Antibodies Trends and Forecast

The future of the global research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets. The global research antibodies market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.

A more than 150-page report is developed to help in your business decisions.

Research Antibodies by Segment

The study includes a forecast for the global research antibodies by product, type, technology, end use, and region.

Research Antibodies Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Primary Antibodies
  • Secondary Antibodies

Research Antibodies Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monoclonal Antibodies
  • Polyclonal Antibodies

Research Antibodies Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Immunohistochemistry
  • Munofluorescence
  • Western Blotting
  • Flow Cytometry
  • Immunoprecipitation
  • Elisa
  • Others

Research Antibodies Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

Research Antibodies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Research Antibodies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies research antibodies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the research antibodies companies profiled in this report include-

  • Abcam
  • Merck
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Santa Cruz Biotechnology
  • Perkinelmer
  • Becton and Dickinson

Research Antibodies Market Insights

Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..

Within this market, immunohistochemistry will remain the largest segment due to its substantial applications in the detection of enzymes, antigens, tumor suppressor genes, and tumor cell proliferation for cell-based research.

North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.

Features of the Global Research Antibodies Market

Market Size Estimates: Research antibodies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Research antibodies market size by various segments, such as by product, type, technology, end use, and region in terms of value ($B).

Regional Analysis: Research antibodies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, technologies, end uses, and regions for the research antibodies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the research antibodies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the research antibodies market size?

Answer: The global research antibodies market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for research antibodies market?

Answer: The global research antibodies market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the research antibodies market?

Answer: The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.

Q4. What are the major segments for research antibodies market?

Answer: The future of the research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets.

Q5. Who are the key research antibodies market companies?

Answer: Some of the key research antibodies companies are as follows:

  • Abcam
  • Merck
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Santa Cruz Biotechnology
  • Perkinelmer
  • Becton and Dickinson

Q6. Which research antibodies market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..

Q7. In research antibodies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the research antibodies market by product (primary antibodies and secondary antibodies), type (monoclonal antibodies and polyclonal antibodies), technology (immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, elisa, and others), end use (academic & research institutes, contract research organizations, and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Research Antibodies Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Research Antibodies Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Research Antibodies Market by Product
    • 3.3.1: Primary Antibodies
    • 3.3.2: Secondary Antibodies
  • 3.4: Global Research Antibodies Market by Type
    • 3.4.1: Monoclonal Antibodies
    • 3.4.2: Polyclonal Antibodies
  • 3.5: Global Research Antibodies Market by Technology
    • 3.5.1: Immunohistochemistry
    • 3.5.2: Munofluorescence
    • 3.5.3: Western Blotting
    • 3.5.4: Flow Cytometry
    • 3.5.5: Immunoprecipitation
    • 3.5.6: ELISA
    • 3.5.7: Others
  • 3.6: Global Research Antibodies Market by End Use
    • 3.6.1: Academic & Research Institutes
    • 3.6.2: Contract Research Organizations
    • 3.6.3: Pharmaceutical & Biotechnology Companies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Research Antibodies Market by Region
  • 4.2: North American Research Antibodies Market
    • 4.2.2: North American Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others
  • 4.3: European Research Antibodies Market
    • 4.3.1: European Research Antibodies Market by Type: Monoclonal Antibodies and Polyclonal Antibodies
    • 4.3.2: European Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others
  • 4.4: APAC Research Antibodies Market
    • 4.4.1: APAC Research Antibodies Market by Type: Monoclonal Antibodies and Polyclonal Antibodies
    • 4.4.2: APAC Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others
  • 4.5: ROW Research Antibodies Market
    • 4.5.1: ROW Research Antibodies Market by Type: Monoclonal Antibodies and Polyclonal Antibodies
    • 4.5.2: ROW Research Antibodies Market by Technology: Immunohistochemistry, Munofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Research Antibodies Market by Product
    • 6.1.2: Growth Opportunities for the Global Research Antibodies Market by Type
    • 6.1.3: Growth Opportunities for the Global Research Antibodies Market by Technology
    • 6.1.4: Growth Opportunities for the Global Research Antibodies Market by End Use
    • 6.1.5: Growth Opportunities for the Global Research Antibodies Market by Region
  • 6.2: Emerging Trends in the Global Research Antibodies Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Research Antibodies Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Research Antibodies Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abcam
  • 7.2: Merck
  • 7.3: Thermo Fisher Scientific
  • 7.4: Cell Signalling Technology
  • 7.5: Santa Cruz Biotechnology
  • 7.6: PerkinElmer
  • 7.7: Becton and Dickinson